A Study for Identification of Predictive Immune Biomarker in Peripheral Blood for Nivolumab Therapy in NSCLC Patients
Clinical trial NCT03486119 · COMPLETED
Trial details
- NCT number
- NCT03486119
- Sponsor
- Yonsei University
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2018-02-05
- Primary completion
- 2020-07-07
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.